UCB Aims To Tailor Myasthenia Gravis Therapy Options To Patients

With Two Late-Stage Candidates

 
• By John Davis
  
Grand Place, Brussels
Brussels, Where UCB is headquartered • Source: Shutterstock

More from Clinical Trials

More from R&D